GHO Capital Partners and Ampersand Capital Partners Report the Acquisition of Avid Bioservices for ~$1.1B
Shots:
- GHO Capital Partners and Ampersand Capital Partners have agreed to acquire Avid Bioservices in an all-cash transaction for an enterprise value of ~$1.1B
- As per the agreement, GHO and Ampersand will acquire all the Avid’s outstanding shares for $12.50 per share in cash, which accounts for 13.8% premium to Avid's last closing price
- The deal is expected to conclude during Q1’25. Upon closing, Avid will be operated privately under its current name and brand
Ref: Globle Newswire | Image: Avid Bioservices
Related News:- Boston Scientific Reports the Acquisition of Cortex
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
